 Tudor Investment Corp Et Al purchased a new position in MacroGenics Inc NASDAQ:MGNX during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 9,207 shares of the biopharmaceutical companys stock, valued at approximately 257,000. Several other institutional investors and hedge funds also recently modified their holdings of ... 